Cases & Deals

Hookipa Pharma completes $84 million IPO

Clients Hookipa Pharma Inc.

Jones Day served as IP counsel in connection with the $84 million initial public offering of Hookipa Pharma Inc. (NASDAQ: HOOK). Hookipa is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on their proprietary arenavirus platform that is designed to reprogram the body's immune system.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.